Cue Biopharma Correlations
CUE Stock | USD 1.03 0.11 9.65% |
The current 90-days correlation between Cue Biopharma and Candel Therapeutics is 0.03 (i.e., Significant diversification). The correlation of Cue Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Cue Biopharma Correlation With Market
Significant diversification
The correlation between Cue Biopharma and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and DJI in the same portfolio, assuming nothing else is changed.
Cue |
Moving together with Cue Stock
0.81 | DRUG | Bright Minds Biosciences | PairCorr |
0.65 | SABSW | SAB Biotherapeutics | PairCorr |
0.7 | VRNA | Verona Pharma PLC | PairCorr |
Moving against Cue Stock
0.58 | VCNX | Vaccinex | PairCorr |
0.56 | ME | 23Andme Holding | PairCorr |
0.51 | DRMA | Dermata Therapeutics | PairCorr |
0.49 | DOMH | Dominari Holdings | PairCorr |
0.39 | A | Agilent Technologies | PairCorr |
0.38 | VALN | Valneva SE ADR | PairCorr |
0.76 | VINC | Vincerx Pharma | PairCorr |
0.72 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.61 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.49 | DTIL | Precision BioSciences | PairCorr |
0.41 | VRAX | Virax Biolabs Group | PairCorr |
0.31 | SRZNW | Surrozen Warrant | PairCorr |
Related Correlations Analysis
0.75 | -0.65 | -0.27 | -0.08 | -0.58 | CADL | ||
0.75 | -0.67 | -0.49 | -0.09 | -0.37 | CINGW | ||
-0.65 | -0.67 | 0.39 | 0.48 | 0.53 | UNCY | ||
-0.27 | -0.49 | 0.39 | 0.18 | 0.01 | CDIO | ||
-0.08 | -0.09 | 0.48 | 0.18 | -0.14 | SNTI | ||
-0.58 | -0.37 | 0.53 | 0.01 | -0.14 | CVKD | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cue Stock performing well and Cue Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cue Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CADL | 3.10 | (0.63) | 0.00 | (0.33) | 0.00 | 6.70 | 26.59 | |||
CINGW | 11.56 | 0.46 | 0.01 | (0.61) | 14.02 | 36.81 | 95.43 | |||
UNCY | 4.27 | 1.18 | 0.19 | 2.09 | 4.19 | 10.26 | 29.22 | |||
CDIO | 6.13 | (0.39) | 0.01 | 0.05 | 6.37 | 14.81 | 57.04 | |||
SNTI | 11.31 | 5.34 | 0.60 | (1.11) | 5.24 | 7.35 | 391.56 | |||
CVKD | 6.24 | 0.75 | 0.13 | 0.47 | 6.31 | 17.85 | 47.47 |
Cue Biopharma Corporate Management
JD MSc | CEO Director | Profile | |
Kenneth MD | Acting Officer | Profile | |
Steven Almo | CoFounder Board | Profile | |
Matteo MD | Chief Officer | Profile | |
Dr III | CoFounder | Profile | |
Lucinda Warren | Chief Officer | Profile |